Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-058781

CONCERT PHARMACEUTICALS, INC. · CNCE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Nov 15, 2018
Accepted (ET)
Nov 15, 2018 · 5:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Nov 15, 2018P10,000$11.9994A296,975D
Common StockF2Nov 15, 2018P40,000$11.7817A336,975D
Common StockF3holding———44,351IIndirect

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses